Needham & Company Downgrades Vascular Solutions (VASC) to Hold Amid Takeover
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Jefferies Raises Price Target on Teleflex (TFX) Ahead of Vascular Solutions (VASC) Acquisition
December 5, 2016 8:05 AM ESTJefferies reiterated a Hold rating on Teleflex (NYSE: TFX), and raised the price target to $155.00 (from $154.00) ahead of the company's acquisition of Vascular Solutions (NASDAQ: VASC) for $56 per share. Vascular Solutions will be both growth and margin accretive... More
Teleflex (TFX) to Acquire Vascular Solutions (VASC) in $1B Deal
December 2, 2016 6:47 AM ESTVascular Solutions, Inc. (Nasdaq: VASC) announced that it has entered into a definitive agreement to be acquired by Teleflex Incorporated (NYSE: TFX) for a purchase price of $56.00 per share in cash. The transaction implies an equity purchase price of $1.0 billion. Upon completion of the transaction, Vascular Solutions will become a wholly owned subsidiary of Teleflex.
The purchase price represents a 16% premium over Vascular Solutions average closing price during the 90 trading days ended December 1, 2016. In addition, the purchase price is 38.4x the midpoint of the companys preliminary 2017... More
